Garo Armen, EXEC. CHAIR & PRINCIPAL OFF, Director at Protagenic Therapeutics, holds 73.53K shares in Protagenic Therapeutics (Ticker: PTIX), holds 426.50K shares in Agenus (Ticker: AGEN), holds 1.87M shares in MiNK Therapeutics (Ticker: INKT). Most recently, Garo Armen Bought ― shares of Protagenic Therapeutics on Aug 24, 2026 for an estimated value of $13.00K.
What is the percentage of profitable transactions made by Garo Armen?
The percentage of profitable transactions made by Garo Armen is 79%.
What is the average return per transaction made by Garo Armen?
The average return per transaction made by Garo Armen is 107.50%.
What stocks does Garo Armen hold?
Garo Armen holds: PTIX, AGEN, INKT stocks.
What was Garo Armen’s latest transaction?
Garo Armen latest transaction was an Informative Buy of $13.00K.
What was Garo Armen's most profitable transaction?
Garo Armen’s most profitable transaction was an Informative Buy of PTIX stock on August 3, 2026. The return on the trade was 479.20%.
What is Garo Armen's role in Protagenic Therapeutics?
Garo Armen's role in Protagenic Therapeutics is EXEC. CHAIR & PRINCIPAL OFF, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.